End Product Of Vitamin C

. 2011 Oct 28;286(43):37128-36.

doi: 10.1074/jbc.M111.245100. Epub 2011 Aug 31.

Vitamin C degradation products and pathways in the human lens

Affiliations

PMID: 21885436
PMCID: PMC3199460
DOI: 10.1074/jbc.M111.245100

Free PMC article

Vitamin C degradation products and pathways in the human lens

Ina Nemet et al. J Biol Chem. 2011 .

Free PMC article

Abstract

Vitamin C and its degradation products participate in chemical modifications of proteins in vivo through non-enzymatic glycation (Maillard reaction) and formation of different products called advanced glycation end products. Vitamin C levels are particularly high in selected tissues, such as lens, brain and adrenal gland, and its degradation products can inflict substantial protein damage via formation of advanced glycation end products. However, the pathways of in vivo vitamin C degradation are poorly understood. Here we have determined the levels of vitamin C oxidation and degradation products dehydroascorbic acid, 2,3-diketogulonic acid, 3-deoxythreosone, xylosone, and threosone in the human lens using o-phenylenediamine to trap both free and protein-bound adducts. In the protein-free fraction and water-soluble proteins (WSP), all five listed degradation products were identified. Dehydroascorbic acid, 2,3-diketogulonic acid, and 3-deoxythreosone were the major products in the protein-free fraction, whereas in the WSP, 3-deoxythreosone was the most abundant measured dicarbonyl. In addition, 3-deoxythreosone in WSP showed positive linear correlation with age (p < 0.05). In water-insoluble proteins, only 3-deoxythreosone and threosone were detected, whereby the level of 3-deoxythreosone was ∼20 times higher than the level of threosone. The identification of 3-deoxythreosone as the major degradation product bound to human lens proteins provides in vivo evidence for the non-oxidative pathway of dehydroascorbate degradation into erythrulose as a major pathway for vitamin C degradation in vivo.

Figures

**SCHEME 1.**
Oxidative and non-oxidative degradation pathways of DHA (1) into reactive dicarbonyls according to Reihl *et al.* (9), 2,3-DKG (2), 3-deoxythreosone (3), xylosone (4), and threosone (5), and their proposed derivatization products with OPD into corresponding quinoxalines (6–10).

**FIGURE 1.**
Mass spectrometric detection of OPD derivatives of DHA (1) (A; *m/z* 247. 0 → *m/z* 157.0 and *m/z* 247.0 → *m/z* 171.0 transitions), 2,3-DKG (2) (B; *m/z* 265.0 → *m/z* 161.1 and *m/z* 265.0 → *m/z* 185.1 transitions), 3-deoxythreosone (3) (C; *m/z* 175.0 → *m/z* 131.9 and *m/z* 175.0 → *m/z* 156.9 transitions), xylosone (4) (D; *m/z* 220.9 → *m/z* 157.1 and *m/z* 220.9 → *m/z* 161.1 transitions), threosone (5) (E; *m/z* 191.2 → *m/z* 144.1 and *m/z* 191.2 → *m/z* 160.0 transitions) and internal standard (IS) (F; *m/z* 158.5 → *m/z* 91.2 and *m/z* 158.5 → *m/z* 118.1 transitions) by LC-ESI-MS/MS multiple-reaction-monitoring analysis in human lens.

**FIGURE 2.**
**Level of free dicarbonyl quinoxalines from DHA (1), 2,3-DKG (2), 3-deoxythreosone (3), xylosone (4), and threosone (5) in human lenses measured as OPD derivatives.** *Error bars*, S.D.

**FIGURE 3.**
Level of quinoxalines from DHA (1; A), 2,3-DKG (2; B), and xylosone (4; C) reversibly bound to water soluble human lens proteins measured as OPD derivatives *versus* age.

**FIGURE 4.**
Level of quinoxalines from 3-deoxythreosone (3; A and C) and threosone (5; B and D) reversibly bound to WSP (A and B) and WIP (C and D) human lens proteins measured as OPD derivatives *versus* age.

**FIGURE 5.**
Mean ± S.D. levels of quinoxalines from DHA (1), 2,3-DKG (2), 3-deoxythreosone (3), xylosone (4), and threosone (5) reversibly bound to water-soluble (A) and water-insoluble (B) proteins in human lenses (ages 20–80) measured as OPD derivatives. *Error bars*, S.D.

**SCHEME 2.**
**Summary of the major *in vivo* pathways of non-enzymatic protein modifications by ascorbic acid degradation products.**

Cited by 21 articles

Effect of Alternative Preservation Steps and Storage on Vitamin C Stability in Fruit and Vegetable Products: Critical Review and Kinetic Modelling Approaches.

Giannakourou MC, Taoukis PS. Giannakourou MC, et al. Foods. 2021 Oct 29;10(11):2630. doi: 10.3390/foods10112630. Foods. 2021. PMID: 34828909 Free PMC article. Review.
Microelectrode Sensor for Real-Time Measurements of Nitrite in the Living Brain, in the Presence of Ascorbate.

Monteiro T, Dias C, Lourenço CF, Ledo A, Barbosa RM, Almeida MG. Monteiro T, et al. Biosensors (Basel). 2021 Aug 17;11(8):277. doi: 10.3390/bios11080277. Biosensors (Basel). 2021. PMID: 34436079 Free PMC article.
Protein posttranslational modification (PTM) by glycation: Role in lens aging and age-related cataractogenesis.

Fan X, Monnier VM. Fan X, et al. Exp Eye Res. 2021 Sep;210:108705. doi: 10.1016/j.exer.2021.108705. Epub 2021 Jul 20. Exp Eye Res. 2021. PMID: 34297945 Review.
CUPRAC-Reactive Advanced Glycation End Products as Prognostic Markers of Human Acute Myocardial Infarction.

Bayarsaikhan G, Bayarsaikhan D, Oh PC, Kang WC, Lee B. Bayarsaikhan G, et al. Antioxidants (Basel). 2021 Mar 11;10(3):434. doi: 10.3390/antiox10030434. Antioxidants (Basel). 2021. PMID: 33799852 Free PMC article.
Two Faces of Vitamin C in Hemodialysis Patients: Relation to Oxidative Stress and Inflammation.

Chaghouri P, Maalouf N, Peters SL, Nowak PJ, Peczek K, Zasowska-Nowak A, Nowicki M. Chaghouri P, et al. Nutrients. 2021 Feb 27;13(3):791. doi: 10.3390/nu13030791. Nutrients. 2021. PMID: 33673687 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Europe PubMed Central
- PubMed Central
Medical
- MedlinePlus Health Information

End Product Of Vitamin C

Source: https://pubmed.ncbi.nlm.nih.gov/21885436/

End Product Of Vitamin C

Lawrence Desember 05, 2021